Greg Madden

Gregory Madden is a seasoned investment professional with extensive experience in private and public healthcare companies, serving as the Managing Partner at SV Health Investors since August 2002. Gregory is involved in financing, strategy, operations, and financial planning for portfolio companies. Current board roles include positions at Spineology Inc., Miach Orthopaedics, Robling Medical, Packaging Compliance Labs, Onkos Surgical, EBT Medical, and CarePredict, showcasing a strong commitment to healthcare innovation. Previous board engagements include Endotronix, acquired by Edwards Lifesciences, and Leiters, acquired by Welsh Carson. Educational credentials include an MBA from the Questrom School of Business at Boston University and a BA in Philosophy from Colby College.